title: The effect of seed anisotrophy on brachytherapy dose distributions using 125I and 103Pd.
abstract: We have evaluated the effect of the anisotropy of individual seeds on dose distributions for permanent prostate implants using 125I and 103Pd. The dose distributions were calculated for various implants using both the line source and point source calculational formalisms, for two different models of 125I and 103Pd seeds. The dose distributions were compared using cumulative dose volume histograms (DVH) and cumulative difference dose volume histograms (deltaDVH) for the prostate target volume and for the rectum surface. The DVHs could not distinguish between the dose distributions from isotropic and non-isotropic seeds. However, the deltaDVHs were useful in determining the fraction of the target volume for which the difference between the dose distribution for line sources and for point sources exceeded a threshold value. The dose distributions were calculated (1) for all the seeds oriented co-linearly, along either the x-, y-, or z-axis, and (2) for the seeds at randomized orientations, more closely resembling the clinical situation. For all cases, there was a significant difference in the effect of seed anisotropy from the different seed types. For the geometrically simpler test cases with a small number of seeds, the effect of anisotropy on the dose distribution was too large to ignore for any of the seed types investigated. For the idealized pre-plan case, the effect was much smaller. For clinical prostate implants, the calculations done with seeds oriented co-linearly along the z-axis (needle implant axis) were a reasonable approximation for those from simulations of seeds with randomized orientations. Again, the effect of anisotropy varied drastically between different seed models, and also between different clinical cases. However, the effect of anisotropy must be considered in the context of all the other uncertainties in clinical brachytherapy treatments.
authors.affiliation: Physics Education & Research, London Regional Cancer Centre, Canada. patricia.lindsay@lrcc.on.ca
authors.forename: P
authors.initials: P
authors.lastname: Lindsay
authors.forename: J
authors.initials: J
authors.lastname: Battista
authors.forename: J
authors.initials: J
authors.lastname: Van Dyk
mesh_terms: D016880:Anisotropy; D001918:Brachytherapy / Q000379:methods*; D004307:Dose-Response Relationship, Radiation; D006801:Humans; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008962:Models, Theoretical; D010165:Palladium / Q000627:therapeutic use*; D011471:Prostatic Neoplasms / Q000532:radiotherapy; D011868:Radioisotopes / Q000627:therapeutic use*; D011874:Radiometry
chemical_list: D007457:Iodine Radioisotopes; D011868:Radioisotopes; D010165:Palladium